Mammalian experiments provide clear evidence of male line transgenerational effects on health and development from paternal or ancestral early-life exposures such as diet or stress. The few human observational studies to date suggest (male line) transgenerational effects exist that cannot easily be attributed to cultural and/or genetic inheritance. Here we summarise relevant studies, drawing attention to exposure sensitive periods in early life and sex differences in transmission and offspring outcomes. Thus, variation, or changes, in the parental/ancestral environment may influence phenotypic variation for better or worse in the next generation(s), and so contribute to common, non-communicable disease risk including sex differences. We argue that life-course epidemiology should be reframed to include exposures from previous generations, keeping an open mind as to the mechanisms that transmit this information to offspring. Finally, we discuss animal experiments, including the role of epigenetic inheritance and non-coding RNAs, in terms of what lessons can be learnt for designing and interpreting human studies. This review was developed initially as a position paper by the multidisciplinary Network in Epigenetic Epidemiology to encourage transgenerational research in human cohorts.
- epigenetic epidemiology
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
The challenge of common chronic disease
The focus of public health is increasingly on chronic disorders, such as diabetes, cardiovascular disease, mental health and cancer manifesting in adulthood. Unlike monogenic (Mendelian) disorders or infectious disease, where the known primary cause permits an aetiological classification and rational approach to management, common diseases are generally multifactorial in origin with diverse genetic and environmental determinants. This contributes to the highly heterogeneous nature of such conditions, which remain an aetiological and management challenge. A multidisciplinary perspective, which includes genetic analysis, is recognised as the most appropriate approach to studying such conditions.1–3 Genetic associations are now routinely integrated with long-established epidemiological analysis of nutrition, social and other exposures through which health and disease have been traditionally explored.
Extending epidemiology beyond genetics and a single generation
For many years, parental and ancestral experience has been regarded as contributing only indirectly across generations. Clearly, such ‘cultural transmission’, which includes parental nurturing behaviour and social patterning of all kinds, does play an important role in shaping the phenotype/traits of progeny. This is an area of active research integrating information on social circumstances, skills, health and mortality, sometimes across three generations of the same lineage.4 ,5
In contrast, biological inheritance of phenotype from one generation to the next is usually regarded as resulting from transmission of genetic material (DNA) from both parents, plus ‘maternal effects’ either (i) carried within the egg cytoplasm (such as in mitochondria, proteins and RNA molecules), (ii) experienced in utero, primarily through the transplacental passage of nutrients, metabolic signals and toxins, or (iii) experienced early postnatally, via breast feeding and/or the exchange of microbiota. Additionally, the maternal genotype also contributes to the early nutritional environment of progeny through its influence on maternal metabolism during pregnancy. This is best exemplified in studies on insulin sensing and fetal growth.6 It is plausible that a maternal exposure in pregnancy could induce a ‘metabolic cascade’ to subsequent generations, whereby fetal programming could alter later adult metabolism, which, in turn, changes the physiology of the uterus receiving and programming the early embryo of the next generation7 and/or the transplacental metabolic signals to the fetus. Theoretically this process could be genotype independent. The challenges of unravelling the complexities associated with maternal transmission of exposure effects are manifold due to the multiple levels of interdependence (figure 1).
Until recently, paternal exposures prior to conception (other than those known to induce DNA mutations) were assumed to have little or no effect on offspring development, primarily due to the lack of a plausible biological mechanism. So ingrained was this view that confirming a lack of paternal exposure effect has been promoted as a useful ‘control’ for social confounders in the study of maternal exposure effects.8 ,9 However, several robust animal experiments exist showing transgenerational phenotypic effects of exposures via the male line.10–16 Human observational studies (reviewed in17) also support this type of non-genetic transmission.
In light of the emerging evidence for both maternal and paternal transmission of non-genetic, non-cultural effects to progeny, consideration must be given to extend traditional epidemiological methodology to include not only early-life paternal and maternal exposures, but also ancestral exposure data. The consequences of such transmission are potentially profound, particularly in relation to past assumptions underpinning much of epidemiological and genetic analyses. In transgenerational epidemiology, assuming cultural inheritance automatically when results make genetic inheritance implausible (and vice versa) is no longer acceptable.
Framing future transgenerational epidemiological research
Although some have adopted the terms intergenerational, multigenerational and transgenerational to mean specific routes and numbers of generations of transmission,18 we use ‘transgenerational’ in a general sense to describe a measurable outcome in one generation (offspring) with exposures in either the mother or the father (prior to conception), or their respective parents or ancestors. ‘Transgenerational’ was first used in this context in the 1980s for the apparent transmission of the trauma suffered by Holocaust survivors to their unexposed offspring.19 This term was also adopted in early speculation about imprinted genes mediating the transmission of exposure information to the next generation20 and is used in recent reviews of the subject in mammals.15 Importantly, the mechanism of transmission must be primarily non-genetic, although mounting evidence implicates genetic factors as moderators of such effects (see below). In prenatal exposure via the mother, the fetus can be assumed to be directly exposed; and here the outcomes of interest in a ‘transgenerational’ context would be in that child's own offspring.
A priority for transgenerational epidemiology is to describe the range of measurable exposures and outcomes mediating transgenerational effects in humans. That is, what exposure at which life stage in parents, grandparents or distant ancestors is associated with a measurable phenotypic outcome in the offspring or subsequent generations? We suggest this observational research is best done in a setting where the effects of social patterning can be accounted for, thereby distinguishing cultural inheritance from a more direct biological transmission across generations. Defining exposure-sensitive periods associated with transgenerational effects will be highly informative in this regard.
Unlike much of the research in the field to date, it is important that future transgenerational epidemiology should not be restricted to the inheritance of acquired characteristics, or ‘phenotypic transmission’ to the next generation. The exposure is key, not the founder, phenotype. In fact, there need not be a measureable phenotype in the exposed (or intermediate) generation. Similarly, phenotypic outcomes should not only be assumed to be detrimental. Although the usual research design in transgenerational epidemiology is to test associations between parental or ancestral exposure and adverse outcomes in unexposed offspring, transgenerational responses/effects can also be protective ‘adaptations’, potentially lessening the risk of adverse outcomes in successive exposed generations. The latter has been demonstrated in a remarkable male line rat experiment where ancestral carbon tetrachloride-induced liver damage led to heritable, epigenetically mediated, reprogramming of hepatic healing, such that exposure in the third generation did not produce liver cirrhosis.21 Lastly, the exposures associated with transgenerational effects need not be adverse. Enriched environments can induce transgenerational responses in mice.22
In summary, a transgenerational perspective is needed if we are to better understand the determinants of major public health problems and adequately assess the value and feasibility of potential interventions. Studies in the field should not be predicated upon a particular mode of transmission from one generation to the next and should make no assumptions about the relative contributions of cultural, genetic or other molecular mechanisms of inheritance. We need to keep an open mind and design appropriate experiments for testing each potential mode of transmission independently.
Below we summarise human studies by type of exposure and route (paternal or maternal) of transmission. Studies of exposures around the time of conception23–26 are not included.
Compelling historical findings of paternal transgenerational effects in humans come from the Överkalix population in northern Sweden27–31 using samples of individuals born in specified years. Longevity and specific causes of death were linked to detailed historical records of harvests and food supply experienced by previous generations in early life. This series of studies is summarised in table 1. The initial all-cause mortality study27 noted an exposure-sensitive period during mid-childhood (the 'slow growth' period during the few years leading up to the prepubertal growth spurt) but not later in childhood, which was confirmed in a subsequent analysis in 2 of 3 independent cohorts28 and then in a sex-specific analysis of mortality rate in the grandchildren.29 This latter analysis showed mortality rate of men born in the target years was linked to just their paternal grandfather's food supply in mid-childhood, whereas the mortality rate of the women studied was associated solely with the paternal grandmother's food supply. The mortality rate ratio point estimates of grandsons were 1.67 or 0.65 depending on good or poor food supply of the paternal grandfather during the slow growth period (compared with grandsons of grandfathers with moderate food supply). For granddaughters, the comparable figures were 2.13 and 0.72 for good or poor food supply of the paternal grandmother. This intriguing pattern of sex-specific association persisted when the grandchild's early life circumstances were taken into account.30 A recent study31 shows that sudden change in food supply between 0 and 13 years of the paternal grandmother is linked to cardiac deaths in the granddaughters raising the possibility that this type of exposure might underlie some of the transgenerational responses reported earlier. Recently, a discussion paper has been posted32 that used data on the German famine of 1916–1918 to look at height, mental health and educational achievement in the descendants of boys exposed at 9–12 and girls at 8–10 years. Among the third generation, males tend to have better mental health scores if their paternal grandfather was exposed, thus providing support for the importance of exposures in the mid-childhood period.
Human studies of ancestral famine or food supplements during pregnancy on fetal growth of the grandchildren have been recently reviewed.18 The Guatemalan follow-up studies of the descendants of women with nutrition intervention in pregnancy indicated a positive association between improved pregnancy and first-generation progeny nutrition with grandchild development indicators—primarily higher birth weight and increased length.33 However, the findings were complicated by supplement use in pregnancy and breast feeding. Cross-sectional studies of the famine in China showed women exposed in utero and early life had bigger babies.34 A far more precise definition of famine was available in the widely cited Dutch famine studies. At the end of World War II (1944–1945), acute food shortages caused widespread starvation (the Hunger Winter) in the occupied cities of Holland. The first study of multigenerational outcomes concerned birth weights of 1808 firstborn children to mothers, most of them exposed in utero during the famine.35 The birth weights of babies born to women who were exposed to famine in utero (during the first and second trimesters) were lower than babies of non-exposed women. Subsequent prospective studies revealed a more complicated situation; in essence, the first born of women exposed in utero were heavier than controls, while second and third born were lighter at birth, the reverse of what is normally observed.36 ,37 In other analyses, no association was found between prenatal famine exposure and grandchild birth weight, whereas associations were identified between exposure and childhood adiposity in grandchildren.38
The study of the age of onset of paternal smoking on offspring outcomes (study child), using the Avon Longitudinal Study of Parents and Children (ALSPAC), was designed to specifically test the Överkalix hypothesis that mid-childhood was an exposure-sensitive period with respect to transgenerational effects. The initial offspring outcomes were those relevant to the Swedish results such as birth characteristics and body mass index (BMI) at ages 7 and 9 years. ALSPAC data, adjusted for paternal smoking at conception, showed that the earlier the father started smoking, the greater the BMI at 9 years of sons, but not daughters. The greatest association was found in sons of men who commenced smoking before the age of 11.29 Follow-up to age 17 years has just been reported.39 The adjusted mean differences in BMI, waist circumference and total fat mass in the group of sons whose fathers started smoking <11 years, relative to others, increased with age, being significantly greater (eg, an extra 5–10 kg of fat mass) from 13 years onwards. There was no significant BMI association in daughters, but they showed a reduction in total lean mass.
An ALSPAC study of non-smoking ALSPAC mothers, who were exposed in utero to maternal smoking, showed their sons (but not daughters) to be, on average, 61 g bigger at birth compared with babies where neither the study mother or grandmother smoked.40 There were no fetal growth differences if the father's mother had smoked in pregnancy. Misra and colleagues analysed data on maternal and grand-maternal smoking from the Baltimore branch of the US Collaborative Perinatal Project and after many adjustments found there was a 244 g increased weight in offspring of non-smoking mothers if their own mother had smoked prenatally.41 Similarly, in a study of births to non-smoking women participating in the British 1958 birth cohort, after adjustment for gestation, maternal birth weight, maternal height and BMI, there was a mean increase of 45 g in weight in children of mothers exposed in utero to maternal smoking, but no allowance was made for parity.42 Neither of these analyses assessed whether there were different effects according to gender of the offspring.
In addition to studies examining anthropometric measures, a few studies have also examined the transgenerational effects of smoking on asthma. One much-quoted study published in 2005 indicated that the risk of childhood asthma was not only influenced by prenatal maternal smoking, but also by the exposure of the mother in utero to her own mother's smoking.43 The ALSPAC study did not find an effect of maternal exposure in utero on childhood asthma,44 although there was suggestive evidence of paternal prenatal exposure being associated with asthma and persistent wheezing in his daughters. Both findings therefore need to be replicated.
Other paternal line exposures
An experimental study of betel nut (Areca catechu) in CD1 mice indicated that paternal exposure transmitted an increased risk of hyperglycaemia and obesity to non-betel-fed first-generation offspring, especially males.45 This led to an observation study within the Keelung Community-based Integrated Screening Program in Taiwan studying the effect of paternal betel-quid (paan) chewing prior to offspring conception. Chewing usually began around 18 years (Boucher, personal communication) and interestingly, a similar association to that found in mice was observed, with a dose-dependent association of paternal betel-quid use with early metabolic syndrome in the adult offspring who had never chewed betel-quid themselves.46
Conclusions from human observations to date
It is fair to say that publicity related to recent publications31 ,39 has drawn some statistical criticism on the issue of multiple testing. Our response points to there being clear prior hypotheses (see table 1) and coherence between different studies/populations. We recognise that research conclusions that extend the public health paradigm need a higher level of evidence than normal, and further replication is needed. However, taken together the above studies demonstrate transgenerational associations between grandpaternal/paternal exposures and health outcomes that are most unlikely to be due to ‘cultural’ inheritance/social patterning or genetic inheritance in isolation. The demonstration of an exposure-sensitive period in mid-childhood prior to puberty, but not in adolescence, provides compelling evidence for some other form of transmission between generations.
Lessons from animal experiments
This is not the place to review the large number of mammalian experiments characterising transgenerational responses to ancestral exposures. Nevertheless, such experiments have revealed certain features that need to be considered in designing and interpreting human studies.
Sex differences in transgenerational effects
Sex differences occur in most non-communicable diseases, including metabolic diseases, diabetes, hypertension, cardiovascular disease, psychiatric and neurological disorders and cancer, yet the potential role of non-genetic transgenerational effects in mediating this has rarely been investigated.
Mammalian experiments showing transgenerational responses have reported numerous sex-specific effects after exposure during pregnancy or on paternal exposure before breeding. These can affect offspring of both sexes,14 ,45 solely/predominantly males47 ,48 or solely/predominantly females.12 Thus, in line with the Överkalix results, the phenotypic outcomes are generally not sex-limited. The X and Y chromosomal difference between the sexes could potentially contribute to sex-specific transgenerational effects. This could include hormonal effects as well as effects that are independent of sex steroids. A recent review of sexual dimorphism49 emphasises the differential epigenetic processes in the placenta, noting the abundance of X-linked genes involved in placentogenesis and the early unequal gene expression by the sex chromosomes between males and females. Champagne's comment on sex specificity in transgenerational responses highlights the differences in epigenetic plasticity during gamete maturation.50 The large number of rodent examples of sex differences in outcomes indicates that the sex differences in outcomes observed in the few human studies (summarised above) are not unexpected. Despite this, such differences tend to be viewed with suspicion, perhaps because of the dangers of post-hoc subgroup analysis.51 However, with due attention to testing for gender interaction as part of association studies, these sex-specific effects should inform the search for mediating mechanisms in transgenerational responses.
The combination of sex-specific transmissions and outcomes in the Överkalix study are consistent with X and Y chromosome transmission and have led to hypotheses in which the non-recombining part of the Y chromosome could more easily retain epigenetic marks in the gametes52 or carry a genomic stress ‘sensor’ where DNA damage triggers a non-coding RNA response.17 However, it should be noted that some sex-specific transgenerational effects in mice are incompatible with XY transmission.50 ,53 Nevertheless, it is highly plausible that transgenerational responses are one of the determinants of common non-communicable diseases and also of some of the sex differences. Only a transgenerational extension of epidemiological research can address this question.
Variable outcomes across the generations from ancestral exposure
Interestingly, the phenotypic effect of an ancestral exposure can vary across generations. This may reflect a propensity for one sex to transmit but not manifest the transgenerational effect.53 Using unpredictable maternal absence in neonatal mice as a stress-inducing exposure, Franklin et al found transgenerational effects through the male line that included transmission by intermediate males who were not themselves overtly affected.54 This model has been explored further in terms of sperm non-coding RNAs55 (see below). In contrast, other studies have shown that transgenerational effects may become restricted over multiple generations. For example, in a study of maternal high-fat diet exposure in mice, there was an increase in body size and reduced insulin sensitivity that persisted across two generations via both maternal and paternal lineages. However, an examination of third-generation progeny revealed that only females displayed the increased body size phenotype, and this effect was only transmitted via the paternal lineage.56 As highlighted by these authors, an emerging phenomenon is that some traits extinguish via one or both lineages, whereas others persist across generations, suggesting that divergent mechanisms of transmission may be involved at the same time.
The majority of animal experiments have tended to restrict phenotyping of descendants to the system that was disturbed by the ancestral exposure, for example, dietary exposures with metabolic dysfunction, stress with behavioural outcomes. Given our present state of ignorance, such limited analysis is unwise. Most human multigenerational cohorts have a range of measures that would allow studies to address the question of whether outcomes in descendants are limited to the system being challenged by the exposures or can be of a more generic character. Interestingly, a recent mouse study using a stress-inducing exposure found both behavioural and metabolic disturbances in descendants.55
Possible mediating molecular mechanisms
A true transgenerational effect has several steps:—exposure; the biological embedding or ‘capture’ of the exposure (this may include DNA damage/mutation); transmission of this information between generations; and phenotypic change in (unexposed) offspring/descendants, potentially associated with fetal programming. The mediating mechanism may vary between steps/generations and therefore may require independent investigation as part of an epidemiological framework.
Transmission between generations
As noted above (figure 1), transmission of exposure information down the maternal line may have several different routes with potential to confound any specific mechanism. Thus, proof-of-principle studies often focus on the male line, even if the initial exposure is during fetal development via the pregnant mother/dam. In the latter situation, the exposed pregnant individual is usually termed F0.
Irrespective of the exposure type and timing, a prerequisite for transgenerational effects beyond the second generation is the involvement of germline transmission, which may occur in several ways. First, by directly impacting on the developing primordial germ cells early in utero, as has been reported in mice.57 In this instance, resulting gametes produced later in life might be anticipated to carry a transmissible ‘memory’ of the original exposure via the mother that can be passed on to subsequent generations. Alternatively, any effect transmitted to the F2 generation via F1 gametes might arise purely in response to the altered development or metabolism of the F1 generation arising from the F0 exposure (see Aiken and Ozanne7 for a discussion of such ‘propagational programming’). These are two distinct processes, each of which might mediate the effects of an F0 exposure on the F2 and subsequent generations, independently of non-gametic maternal effects. It is worth noting that even male gametic transmission does not necessarily require the molecular ‘memory’ of the original exposure to pass through meiosis. There are tight cell–cell junctions between Sertoli-cells and postmeiotic spermatids that theoretically could act as a route for ‘message delivery’ to the zygote and beyond,58 and recent work has shown an influence of seminal fluid in conjunction with uterine factors on offspring metabolic development.59
A role for epigenetics in transgenerational responses
Epigenetic events are an essential mediator of cellular differentiation and therefore development in multicellular organisms. However, the underlying dynamism and responsiveness to subtle subcellular cues that are a hallmark of epigenetic change during development also make the developing epigenetic profile susceptible to external influence, with the potential to ‘program’ the underlying genome towards an altered phenotype in later life.60 The labile nature of some epigenetic marks to environmental influence has made epigenetic processes an appealing mechanism for transgenerational responses. In fact, transgenerational epigenetic inheritance has been widely documented in prokaryotes, fungi, plants and animals, via both the male and female germline. In at least some instances (eg, in Caenorhabditis elegans), initial transmission down the female line can ‘spread’ to encompass paternal transmission in subsequent generations.61
In mammals, data demonstrating the erasure of nearly all epigenetic marks twice during the life course (early postzygotically and in the developing primordial germ cells in early development) have been difficult to reconcile with an epigenetic mode of transgenerational effects. Nevertheless, for decades it has been known that mammals have a set of imprinted genes; those that are selectively silenced in either the maternal or paternal germline during gamete formation, such that only one allele is expression following fertilisation. Genomic imprinting establishes the principle of transgenerational epigenetic inheritance—the gene is active or silent depending on epigenetic marks placed in the parental generation that survive erasure as they pass to the offspring.62 The parent-of-origin-dependent gene expression reflects a robust, evolved response to differences in cellular conditions between egg and sperm development. Imprinted genes escape one of the two phases of genome demethylation between generations, namely in the preimplantation embryo soon after fertilisation.63 Importantly, the epigenetic marks that regulate some imprinting regions have been demonstrated to show interindividual, tissue-specific, age-specific and environmentally sensitive variation.25 ,64–72
Recent mouse experiments have also reported a small percentage of loci that escape demethylation at the second phase during primordial gonadal cell differentiation in the early embryo. These are largely associated with repeat sequences, often adjacent to transposable DNA elements.73 Interestingly, there is growing evidence that some repeat-based transposable elements have gene enhancer activity.74 It is also now clear that many non-imprinted, non-repetitive genomic loci remain subject to epigenetic control in both sperm and eggs. This applies to both DNA methylation75 ,76 and histone modification profiles.77 ,78 Further, emerging data exist that demonstrate intergametic variation in epigenetic profile, supporting a role for environmental and/or genetic influence in determining the epigenetic state transmitted to the next generation.79 ,80
Of particular note is a recent study in mice that provides a plausible mechanism for transgenerational inheritance of environmental information, linking behavioural, neuroanatomical and epigenetic processes. Using an olfactory fear conditioning protocol, wherein an odour (acetophenone) is paired with a mild foot-shock, Dias et al noted a behavioural sensitivity to acetophenone in the next two generations of animals, despite having no exposure to this odour. This was associated with structural changes in the olfactory nervous system accompanying the fear conditioning and distinct hypomethylation of the Olfr151 gene (known to be activated by acetophenone) in sperm of conditioned F0 males and F1-naive offspring.16 The extent to which other specific environmental exposures elicit similarly specific epigenetic changes in gametes, and the extent to which these are retained during postzygotic development, remains unclear but warrants further investigation.
Another recent study in a non-genetic prediabetes mouse model provides further compelling evidence for gametic transmission of environmentally induced epigenetic change.81 In this model, offspring of prediabetic fathers show glucose intolerance and insulin resistance in association with distinct changes in gene expression and DNA methylation patterns in pancreatic islets, including reproducible changes in methylation of insulin signalling genes. Interestingly, the sperm of prediabetic fathers have extensive changes in methylation patterns in sperm, many of which overlapped with that of pancreatic islets in offspring.81
Non-coding RNAs (ncRNAs) as mediators of transgenerational responses
There is evidence for a role of sperm-derived RNAs in mediating paternal transgenerational effects, with several classes of RNA recently identified in sperm that are likely to be essential factors in male fertility, including many Y-linked ncRNAs.82 Such RNAs have the potential to play roles in early postfertilisation development.83
The specific RNA content of sperm has been assessed in response to specific environmental exposures. Diet-induced paternal obesity in mice alters microRNA (miRNA) content and sperm methylation status in male mice in association with altered metabolic function in two subsequent generations of progeny.84 Chronic stress in male mice results in altered miRNA content of sperm in association with reduced HPA stress axis responsiveness in the progeny.85 Recently, exploiting their transgenerational model of unpredictable maternal absence in neonatal mice as a stress-inducing exposure, Mansuy's group have examined the associated miRNA changes in sperm. Injection of sperm RNAs from exposed males into fertilised wild-type oocytes reproduced the behavioural and metabolic alterations in the resulting offspring. Interestingly, affected F2 mice had normal sperm miRNAs, yet their F3 offspring still inherited the behavioural phenotype.55 In humans, the small RNA component of sperm is altered in male smokers, including miRNAs predicted to target the epigenetic regulators.86 As a whole, the emerging picture suggests that the RNA content of sperm is sensitive to environmental exposures, with the potential to influence early embryonic development, including the establishment of the postzygotic epigenome. This is speculated to be an initiating mechanism for transmission of impaired metabolic health to future generations via the male lineage.84
A modifying role for genetics in mediating transgenerational effects
Genetic variation will clearly impact to a variable extent on the apparent heritability of some epigenetic marks as evidenced by multigenerational familial studies87 and exemplified at one extreme by MLH1 germline epimutation analysis. Originally thought to be solely due to inheritance of a ‘pure’ epigenetic variant (DNA hypermethylation) across generations,88 in some cases this is genetically driven, being erased in the germline but faithfully re-established early postzygotically in association with a proximal genetic variant or haplotype.89 ,90 Epigenetic responses to exposures and the propensity to be transmitted to the next generation(s) are likely to have evolved under selective pressure. As such one can expect variation in ‘responsiveness’ to a specific exposure to be underpinned by genetic differences. Compelling data in support of this have recently emerged, highlighting the potential of genetic variation in both cis (regions on the same chromosome) and trans (different chromosome) to mediate the effects of environmental exposures on the neonatal epigenetic profile in humans.91 As such, any study of environmentally driven epigenetic variation transmitted transgenerationally needs to considered on a background of genetic variation as a modifier of this effect. For example, although genetic differences may contribute directly to the phenotype in a specific environment, in a classic G×E manner, the additional layer of epigenetic regulation has the potential to make such effects more nuanced on certain genetic backgrounds. Alternatively, some transgenerational environmentally induced epigenetically mediated effects may be exacerbated in association with other ‘risk’ genotypes. Finally, some transgenerational phenotypic effects are likely to be completely independent of genotype.
Different transmitting mechanisms within the same lineage
As described above, environmental exposures can potentially initiate transgenerational effects through altered miRNA in sperm, but some aspects of the phenotype can be transmitted to later generations in the absence of the original miRNA change.55 This separation of initiation and later transmission has been explored using experimental genetic changes. For example, experimental genetic effects in rodents can set up a developmental environment that promotes transgenerational responses in the absence of the genetic change, for example, by changing weight and food intake in subsequent generations.92 It is plausible that ‘random’ somatic mutations leading to substantial mosaicism might induce epigenetic or ncRNA changes that in turn initiate transgenerational effects, or exposures can induce DNA damage as the first step, for example, stress-related DNA damage.93 Further, recent data in mice have revealed that genetic variation in the genes regulating one carbon metabolism can manifest as distinct and reproducible phenotypic variation across multiple systems and generations.94 Importantly, these defects were dependent upon the genotypes of the maternal grandparents. Embryo transfer experiments revealed that haploinsufficiency in mice leads to two distinct, separable phenotypes: adverse effects on their wild-type daughters' uterine environment, leading to growth defects in wild-type grandprogeny, and the appearance of congenital malformations independent of maternal environment that persist for five generations, likely through transgenerational epigenetic inheritance.94
What is needed for future human studies?
Non-genetic biological transmission between generations, of which epigenetic hypotheses are an exemplar, spell out how exposures in one generation may lead to effects on health, behaviour or other personal characteristics in later generations. To date human studies of transgenerational responses have ranged from historical analysis of the Överkalix cohorts for which biological samples are not available (at least for all but the 1935 cohort) to the contemporary birth cohort ALSPAC where samples are available on the mother and offspring, plus limited paternal samples. The collection of blood or tissue samples is often seen as the next step to further our knowledge about transgenerational mechanisms in humans. Discoveries of epigenetic and other mechanisms in cells may indeed further our understanding of the aetiological relations. However, this does not mean that large population studies without direct information from human blood or tissue are redundant. On the contrary, epigenetic hypotheses that predict that a specific exposure in one generation will give rise to a specific outcome in a later generation(s) could and should be tested in large-scale population studies that hold information about such exposures and outcomes. Conventional non-experimental epidemiological studies can still provide an effective means to explain and potentially prevent (adverse) transgenerational responses. Public health interventions may be applied at many different entry points in the aetiological chain of events. Often one and the same condition may be causally attributed to different aetiological antecedents in the web of causation dependent on whether the focus of the study is primarily preventive, predictive, therapeutic or, more generally, explanatory.95 ,96
There are many birth cohorts and other general population samples worldwide (table 2), and current life-course epidemiology is well placed to extend its reach beyond a single generation and the DNA sequence. It is important to note that from the public health perspective, studying the effect of just early-life parental exposures is likely to increase our understanding of the phenotypic variation, health and well-being of the offspring generation, and perhaps point the way to intervention trials. Common parental exposure information is likely to be available, or could be collected, in many of the existing cohorts. Going forward, the primary aim of human studies may not be to test a particular mechanistic theory, although studies over three generations with biological samples are likely to be informative in this respect. However, it will be important to pay particular attention to the parental/ancestral exposures, both in terms of dose and timing of the exposure in relation to the person's stage of development—ideally with prospectively collected information. Standardisation of outcome measures across cohorts is important for many epidemiological studies, including transgenerational studies, and is being actively addressed.
Many cohorts are establishing DNA banks, but it is also worth bearing in mind that neonatal blood spots (Guthrie cards), collected and stored for many decades in some countries, can be a valuable resource for capturing neonatal epigenome and other data.97 In light of the role of miRNAs, discussed above, the collection of cell-free circulating miRNAs is likely to be a valuable additional resource.98 In terms of ‘future proofing’, serious consideration should be given to storing ‘living genomes’ in the form of EBV-transformed lymphoblastoid cell lines or other viable cells derived from primary tissues (eg, induced pluripotent stem cells). The value of such cells in assessing epigenome associations with early-life experience is an active research area, including how to deal with possible culture-induced genetic and epigenetic changes. If such approaches prove useful, this will offer considerable opportunities for life course and transgenerational epidemiology.
This position paper was developed by the multidisciplinary Network in Epigenetic Epidemiology to encourage transgenerational research in human cohorts. This group (see ‘Contributors’) met four times at the Karolinska Institute since 2009.
Collaborators LOB, MP, RS, John Carstensen, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. Sören Edvinsson, 1. Demographic Data Base, Umeå University, Umeå, Sweden, 2. Centre for Population Studies, Umeå University, Umeå Sweden. Tomas Faresjö, Department of Medicine and Health, Unit of Community Medicine/General Practice, Linköping University, Linköping, Sweden. Paul Franks, 1. Genetic and Molecular Epidemiology Unit, Lund University Diabetes Center, Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden, 2. Department of Nutrition, Harvard School of Public Health, Boston, MA, USA, 3. Department of Public Health and Clinical Medicine, Section for Medicine, Umeå University, Umeå, Sweden. Jan-Åke Gustafsson, 1.Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden, 2. Center for Nuclear Receptors and Cell Signaling, University of Houston, Texas, USA. Gunnar Kaati, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden. B.I.B.Lindahl, Department of Philosophy, Stockholm University, Stockholm, Sweden, Johnny Ludvigsson, Department of Paediatrics, Unit of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. L. H. Lumey, Department of Epidemiology, Mailman School of Public health, Columbia University, New York, New York, USA. Bitte Modin, Centre for Health Equity Studies (CHESS), Stockholm University/Karolinska Institutet, Stockholm, Sweden. Hans Nilsson, Department for Studies of Social Change and Culture, Linköping University, Sweden. Michael Sjöström, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden. Petter Tinghög, Department of Clinical Neurosciences, Karolinska Institutet, Solna, Sweden, Denny Vågerö, Centre of Health and Equity Studies (CHESS), Stockholm University/Karolinska Institutet, Stockholm, Sweden.
Contributors LOB established and led The Network in Epigenetic Epidemiology, MP and RS drafted this review/position paper drawing on the discussions of the Network. These Network members scrutinised and commented on this final and earlier drafts.
Funding The Network in Epigenetic Epidemiology was funded by the Swedish Research Council for Health, Working Life and Welfare. Dnr 2008-1153, 2009-2022 and 2010-1421; and also the UK Medical Research Council grant G1100226 to MP.
Competing interests None.
Patient consent No.
Provenance and peer review Commissioned; internally peer reviewed.